These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26770355)

  • 1. Controlled attenuation parameter for assessment of hepatic steatosis grades: a diagnostic meta-analysis.
    Wang Y; Fan Q; Wang T; Wen J; Wang H; Zhang T
    Int J Clin Exp Med; 2015; 8(10):17654-63. PubMed ID: 26770355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled attenuation parameter for the detection of steatosis severity in chronic liver disease: a meta-analysis of diagnostic accuracy.
    Shi KQ; Tang JZ; Zhu XL; Ying L; Li DW; Gao J; Fang YX; Li GL; Song YJ; Deng ZJ; Wu JM; Tang KF
    J Gastroenterol Hepatol; 2014 Jun; 29(6):1149-58. PubMed ID: 24476011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease.
    Chan WK; Nik Mustapha NR; Mahadeva S
    J Gastroenterol Hepatol; 2014; 29(7):1470-6. PubMed ID: 24548002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of controlled attenuation parameter measured by transient elastography for the non-invasive assessment of liver steatosis: a prospective study.
    Lupșor-Platon M; Feier D; Stefănescu H; Tamas A; Botan E; Sparchez Z; Maniu A; Badea R
    J Gastrointestin Liver Dis; 2015 Mar; 24(1):35-42. PubMed ID: 25822432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled attenuation parameter and alcoholic hepatic steatosis: Diagnostic accuracy and role of alcohol detoxification.
    Thiele M; Rausch V; Fluhr G; Kjærgaard M; Piecha F; Mueller J; Straub BK; Lupșor-Platon M; De-Ledinghen V; Seitz HK; Detlefsen S; Madsen B; Krag A; Mueller S
    J Hepatol; 2018 May; 68(5):1025-1032. PubMed ID: 29343427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience.
    Baumeler S; Jochum W; Neuweiler J; Bergamin I; Semela D
    Swiss Med Wkly; 2019 Apr; 149():w20077. PubMed ID: 31026041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of B-mode ultrasound-based attenuation for the diagnosis of hepatic steatosis: a systematic review/meta-analysis.
    Hirooka M; Koizumi Y; Sunago K; Nakamura Y; Hirooka K; Watanabe T; Yoshida O; Tokumoto Y; Abe M; Hiasa Y
    J Med Ultrason (2001); 2022 Apr; 49(2):199-210. PubMed ID: 35239088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis.
    Karlas T; Petroff D; Sasso M; Fan JG; Mi YQ; de Lédinghen V; Kumar M; Lupsor-Platon M; Han KH; Cardoso AC; Ferraioli G; Chan WK; Wong VW; Myers RP; Chayama K; Friedrich-Rust M; Beaugrand M; Shen F; Hiriart JB; Sarin SK; Badea R; Jung KS; Marcellin P; Filice C; Mahadeva S; Wong GL; Crotty P; Masaki K; Bojunga J; Bedossa P; Keim V; Wiegand J
    J Hepatol; 2017 May; 66(5):1022-1030. PubMed ID: 28039099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis.
    Pu K; Wang Y; Bai S; Wei H; Zhou Y; Fan J; Qiao L
    BMC Gastroenterol; 2019 Apr; 19(1):51. PubMed ID: 30961539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical usefulness of controlled attenuation parameter to screen hepatic steatosis for potential donor of living donor liver transplant.
    Hong YM; Yoon KT; Cho M; Chu CW; Rhu JH; Yang KH; Lee JW
    Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):805-810. PubMed ID: 28379854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of controlled attenuation parameter in diagnosis of fatty liver using FibroScan].
    Xu L; Li P; Lu W; Shi Q; Shi R; Zhang X; Liu Y; Wang Q; Fan J; Mi Y
    Zhonghua Gan Zang Bing Za Zhi; 2016 Feb; 24(2):108-13. PubMed ID: 26983477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative ultrasound radiofrequency data analysis for the assessment of hepatic steatosis using the controlled attenuation parameter as a reference standard.
    Jeon SK; Joo I; Kim SY; Jang JK; Park J; Park HS; Lee ES; Lee JM
    Ultrasonography; 2021 Jan; 40(1):136-146. PubMed ID: 32654442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.
    de Lédinghen V; Vergniol J; Foucher J; Merrouche W; le Bail B
    Liver Int; 2012 Jul; 32(6):911-8. PubMed ID: 22672642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The B-Mode Image-Guided Ultrasound Attenuation Parameter Accurately Detects Hepatic Steatosis in Chronic Liver Disease.
    Fujiwara Y; Kuroda H; Abe T; Ishida K; Oguri T; Noguchi S; Sugai T; Kamiyama N; Takikawa Y
    Ultrasound Med Biol; 2018 Nov; 44(11):2223-2232. PubMed ID: 30077415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled attenuation parameter for steatosis grading in chronic hepatitis C compared with digital morphometric analysis of liver biopsy: impact of individual elastography measurement quality.
    Mendes LC; Ferreira PA; Miotto N; Zanaga L; Lazarini MS; Gonçales ESL; Pedro MN; Gonçales FL; Stucchi RSB; Vigani AG
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):959-966. PubMed ID: 29727388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ultrasound-guided attenuation parameter is useful in quantification of hepatic steatosis in non-alcoholic fatty liver disease.
    Ogino Y; Wakui N; Nagai H; Igarashi Y
    JGH Open; 2021 Aug; 5(8):947-952. PubMed ID: 34386604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can the same controlled attenuation parameter cut-offs be used for M and XL probes for diagnosing hepatic steatosis?
    Chan WK; Nik Mustapha NR; Mahadeva S; Wong VW; Cheng JY; Wong GL
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1787-1794. PubMed ID: 29603365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between Controlled Attenuation Parameter and Hepatic Steatosis as Assessed by Ultrasound in Alcoholic or Nonalcoholic Fatty Liver Disease.
    Ahn JM; Paik YH; Min SY; Cho JY; Sohn W; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Gut Liver; 2016 Mar; 10(2):295-302. PubMed ID: 26347511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of hepatic steatosis index, controlled attenuation parameter and ultrasound as noninvasive diagnostic tools for steatosis in chronic hepatitis B.
    Xu L; Lu W; Li P; Shen F; Mi YQ; Fan JG
    Dig Liver Dis; 2017 Aug; 49(8):910-917. PubMed ID: 28433586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of hepatic steatosis using the controlled attenuation parameter: a comparative study with liver biopsy.
    Yilmaz Y; Yesil A; Gerin F; Ergelen R; Akin H; Celikel ÇA; Imeryuz N
    Scand J Gastroenterol; 2014 May; 49(5):611-6. PubMed ID: 24611771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.